Global Respiratory Distress Syndrome Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Respiratory Distress Syndrome market size will reach 467.65 Million USD in 2025 and is projected to reach 681.64 Million USD by 2032, with a CAGR of 5.53% (2025-2032). Notably, the China Respiratory Distress Syndrome market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Respiratory Distress Syndrome (RDS), also known as hyaline membrane disease, is a serious respiratory condition primarily affecting premature infants. It is characterized by insufficient production of surfactant, a substance that helps keep the air sacs in the lungs open and facilitates breathing. Without adequate surfactant, the infant's lungs become stiff, making it difficult for them to expand and contract properly. This results in respiratory difficulties, including rapid breathing, labored breathing, and low oxygen levels in the blood. RDS is most common in infants born before 28 weeks of gestation, as surfactant production usually begins in the third trimester of pregnancy. Treatment often involves providing respiratory support through mechanical ventilation and administering exogenous surfactant. While advancements in neonatal care have improved outcomes, RDS remains a significant challenge in the care of premature infants.
The major global suppliers of Respiratory Distress Syndrome include Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Respiratory Distress Syndrome. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Respiratory Distress Syndrome market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Respiratory Distress Syndrome market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Respiratory Distress Syndrome industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Respiratory Distress Syndrome Include:
Chiesi Farmaceutici
CR-Double Crane
ONY Biotech
AbbVie
Yuhan Corporation
JW Pharmaceuticals
Noargen
Respiratory Distress Syndrome Product Segment Include:
Poractant Alfa
Beractant
Calfactant
Others
Respiratory Distress Syndrome Product Application Include:
Very Preterm Infants
Moderate to Late Preterm Infants
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Respiratory Distress Syndrome Industry PESTEL Analysis
Chapter 3: Global Respiratory Distress Syndrome Industry Porter's Five Forces Analysis
Chapter 4: Global Respiratory Distress Syndrome Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Respiratory Distress Syndrome Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Respiratory Distress Syndrome Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Respiratory Distress Syndrome Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Respiratory Distress Syndrome market size will reach 467.65 Million USD in 2025 and is projected to reach 681.64 Million USD by 2032, with a CAGR of 5.53% (2025-2032). Notably, the China Respiratory Distress Syndrome market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Respiratory Distress Syndrome (RDS), also known as hyaline membrane disease, is a serious respiratory condition primarily affecting premature infants. It is characterized by insufficient production of surfactant, a substance that helps keep the air sacs in the lungs open and facilitates breathing. Without adequate surfactant, the infant's lungs become stiff, making it difficult for them to expand and contract properly. This results in respiratory difficulties, including rapid breathing, labored breathing, and low oxygen levels in the blood. RDS is most common in infants born before 28 weeks of gestation, as surfactant production usually begins in the third trimester of pregnancy. Treatment often involves providing respiratory support through mechanical ventilation and administering exogenous surfactant. While advancements in neonatal care have improved outcomes, RDS remains a significant challenge in the care of premature infants.
The major global suppliers of Respiratory Distress Syndrome include Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Respiratory Distress Syndrome. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Respiratory Distress Syndrome market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Respiratory Distress Syndrome market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Respiratory Distress Syndrome industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Respiratory Distress Syndrome Include:
Chiesi Farmaceutici
CR-Double Crane
ONY Biotech
AbbVie
Yuhan Corporation
JW Pharmaceuticals
Noargen
Respiratory Distress Syndrome Product Segment Include:
Poractant Alfa
Beractant
Calfactant
Others
Respiratory Distress Syndrome Product Application Include:
Very Preterm Infants
Moderate to Late Preterm Infants
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Respiratory Distress Syndrome Industry PESTEL Analysis
Chapter 3: Global Respiratory Distress Syndrome Industry Porter's Five Forces Analysis
Chapter 4: Global Respiratory Distress Syndrome Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Respiratory Distress Syndrome Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Respiratory Distress Syndrome Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Respiratory Distress Syndrome Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Respiratory Distress Syndrome Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Respiratory Distress Syndrome Product by Type
- 1.2.1 Poractant Alfa
- 1.2.2 Beractant
- 1.2.3 Calfactant
- 1.2.4 Others
- 1.3 Respiratory Distress Syndrome Product by Application
- 1.3.1 Very Preterm Infants
- 1.3.2 Moderate to Late Preterm Infants
- 1.3.3 Others
- 1.4 Global Respiratory Distress Syndrome Market Size Analysis (2020-2032)
- 1.5 Respiratory Distress Syndrome Market Development Status and Trends
- 1.5.1 Respiratory Distress Syndrome Industry Development Status Analysis
- 1.5.2 Respiratory Distress Syndrome Industry Development Trends Analysis
- 2 Respiratory Distress Syndrome Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Respiratory Distress Syndrome Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Respiratory Distress Syndrome Market Analysis by Country
- 4.1 Global Respiratory Distress Syndrome Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Respiratory Distress Syndrome Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Respiratory Distress Syndrome Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Respiratory Distress Syndrome Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Respiratory Distress Syndrome Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Respiratory Distress Syndrome Market Revenue and Growth Rate (2020-2032)
- 4.5 China Respiratory Distress Syndrome Market Revenue and Growth Rate (2020-2032)
- 4.6 France Respiratory Distress Syndrome Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Respiratory Distress Syndrome Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Respiratory Distress Syndrome Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Respiratory Distress Syndrome Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Respiratory Distress Syndrome Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Respiratory Distress Syndrome Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Respiratory Distress Syndrome Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Respiratory Distress Syndrome Market Revenue and Growth Rate (2020-2032)
- 4.14 India Respiratory Distress Syndrome Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Respiratory Distress Syndrome Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Respiratory Distress Syndrome Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Respiratory Distress Syndrome Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Respiratory Distress Syndrome Market Revenue by Key Suppliers (2021-2025)
- 5.2 Respiratory Distress Syndrome Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Respiratory Distress Syndrome Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Respiratory Distress Syndrome Market Analysis by Type
- 6.1 Global Respiratory Distress Syndrome Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Respiratory Distress Syndrome Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Chiesi Farmaceutici
- 7.1.1 Chiesi Farmaceutici Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Chiesi Farmaceutici Respiratory Distress Syndrome Product Portfolio
- 7.1.3 Chiesi Farmaceutici Respiratory Distress Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 CR-Double Crane
- 7.2.1 CR-Double Crane Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 CR-Double Crane Respiratory Distress Syndrome Product Portfolio
- 7.2.3 CR-Double Crane Respiratory Distress Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 ONY Biotech
- 7.3.1 ONY Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 ONY Biotech Respiratory Distress Syndrome Product Portfolio
- 7.3.3 ONY Biotech Respiratory Distress Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 AbbVie
- 7.4.1 AbbVie Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 AbbVie Respiratory Distress Syndrome Product Portfolio
- 7.4.3 AbbVie Respiratory Distress Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Yuhan Corporation
- 7.5.1 Yuhan Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Yuhan Corporation Respiratory Distress Syndrome Product Portfolio
- 7.5.3 Yuhan Corporation Respiratory Distress Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 JW Pharmaceuticals
- 7.6.1 JW Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 JW Pharmaceuticals Respiratory Distress Syndrome Product Portfolio
- 7.6.3 JW Pharmaceuticals Respiratory Distress Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Noargen
- 7.7.1 Noargen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Noargen Respiratory Distress Syndrome Product Portfolio
- 7.7.3 Noargen Respiratory Distress Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Respiratory Distress Syndrome Industry Chain Analysis
- 8.2 Respiratory Distress Syndrome Product Downstream Application Analysis
- 8.2.1 Global Respiratory Distress Syndrome Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Respiratory Distress Syndrome Revenue and Forecast by Application (2020-2032)
- 8.3 Respiratory Distress Syndrome Typical Downstream Customers
- 8.4 Respiratory Distress Syndrome Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
